André Görgens’ Post

NEW PRODUCT LAUNCH! Are your cell lines producing aggregated mAbs? Screen them faster with a newer, faster method. Don't miss this webinar from Beckman Coulter Life Sciences on how: #DanaherLifeSciences #BeckmanCoulterLifeSciences #mAb #rProtein

Transforming the impossible into the inevitable! Discover how researchers are tackling undruggable targets with innovative strategies. From allosteric modulation to covalent ligands, the future of drug discovery looks brighter. Read more in our latest blog post. https://bit.ly/3Vathe3

Preliminary agendas now available: Bioprocessing Summit Europe brings together 750+ upstream, downstream, bioproduction, and analytical professionals from industry and academia to advance the manufacture, quality, and control of next generation biologics and genetic therapies. This 3-day, 14-track meeting has quickly become a premier event in the European bioprocessing calendar and focuses on the latest innovations in bioprocess R&D as well as the practical solutions to enhance efficiency, speed and cost in biomanufacturing. New for 2025, we are excited to add a new conference stream on #processmodelling and #digitalization, alongside expanded content on #ML/AI, #advanced process control, #developability, #cell culture, #downstream processing, #analytics, and the latest in #celltherapy, #genetherapy, and #RNA therapies. https://lnkd.in/gPypE9E #CHIBioprocessingSummit

Our latest blog post, "Finding new active molecule 6x faster with DeepMirror" is live! Optimising ADMET properties is an essential step in drug discovery and is a major cause of clinical drug failure. In our latest blogpost, we show how a European biotech, previously stuck with scaffolds with good potency but adverse ADMET, used DeepMirror to identify new highly potent molecular scaffolds with better ADMET properties in 2 weeks instead of 3 months. You can read it here: https://lnkd.in/dicU-BWx

In this panel discussion, we talked with industry experts about current antibody titer expectations, analytical challenges and how real time titer measurement is a game changer for bioproduction moving forward. https://lnkd.in/gJF3ygt6 #antibodytiter

Not only is the story of #CHO cells fascinating but their role in the production of life-saving active ingredients and in supporting #scientificresearch is absolutely amazing! Tens of the new drugs approved for human use every year and hundreds of the most innovative drugs on the market are produced thanks to CHO cells. 👉 But thinking that one CHO cell line is much like another is misleading... in fact different cell lines have different genetic characteristics of course but also different "behaviors“ and "tastes"... as we're talking about living organisms. 👉 at Magellan Biologics & Consulting we're working with CHO 4Tx®, a robust proprietary CHO cell line that was optimized for transient transfection. 👉 Since we know what our cells like, we have developed 3 media: one to cultivate them, one to transfect them - by simply adding DNA and one to feed and stimulate them once the transfection is effective, up to 14 days without additional feed. 👉 Since we know how they behave and what we can expect from them, in terms of viability and yield, we have developed a protocol which offers them a perfect work-life balance! 👉 Since we know we can trust them, you could trust them too! Want to know more about CHO 4Tx®? Please visit us on: https://lnkd.in/dBxfj8_D

🔬 Discover the Power of Collaboration The IIMCB organized Industry Day, where science and business joined efforts to foster innovation. 💊🧪🧬 4 leading biotech companies: Adamed Pharma, Bacteromic, ExploRNA Therapeutics, and Selvita. presented their cutting-edge projects, ranging from microbiological diagnostics and drug development to groundbreaking mRNA research. The event also featured an insightful discussion on the role of AI in research and the importance of investing in basic science for industry growth. 🔍 Curious about the synergy between academia and industry? Learn more about how these partnerships shape the future of biotech! 🔗 Read the full article here: bit.ly/IndustryDay-2024 #Collaboration #Biotech #Industry #Research #RACE #RNA #Cell #CentreOfExcellence #REA European Research Executive Agency (REA) Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.

In this panel discussion, we talked with industry experts about current antibody titer expectations, analytical challenges and how real time titer measurement is a game changer for bioproduction moving forward. https://lnkd.in/getVbJGk #antibodytiter

In this poster I am presenting a novel method for developability screening of 6His-Tag containing antibody fragments by PAIA Biotech GmbH. Assessment of hydrophobicity and polyspecificity can now be done in under an hour for hundreds of samples. Meet me at the #PEGSummit on May 13-17 in Boston and let's discuss #proteinresearch ✌ #developability

In this panel discussion, we talked with industry experts about current antibody titer expectations, analytical challenges and how real time titer measurement is a game changer for bioproduction moving forward. https://lnkd.in/getVbJGk #antibodytiter